Related Experiment Video
Updated: Jul 14, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Sex Differences in Long-Term Outcomes of Left Atrial Appendage Closure-Analysis from the LEADER Registry
Aviad Rotholz1,2, Hagai Itach2, Roi Ferman3
1Cardiology Department, Beilinson Hospital, Rabin Medical Center, Ze'ev Jabotinsky St 39, Petah Tikva 4941492, Israel.
Insights
Percutaneous left atrial appendage closure (LAAC) is a safe stroke prevention method for atrial fibrillation (AF) patients. This study found no significant sex differences in procedural or long-term outcomes for LAAC in AF patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Atrial Fibrillation Management
Background:
- Percutaneous left atrial appendage closure (LAAC) offers an alternative to oral anticoagulation (OAC) for atrial fibrillation (AF) patients at high risk of bleeding.
- Previous research suggested higher peri-procedural complication rates in women undergoing LAAC, but long-term outcome data remain inconsistent.
Purpose of the Study:
- To investigate potential sex-based differences in peri-procedural and long-term clinical outcomes following LAAC.
- To evaluate the efficacy and safety of LAAC as a stroke prevention strategy in a real-world AF patient population.
Main Methods:
- Analysis of 407 consecutive AF patients who underwent LAAC between 2010 and 2023 across four Israeli medical centers (LEADER registry).
- Comparison of baseline characteristics, procedural data, and clinical outcomes between male and female patients.
- Primary endpoints included ischemic stroke/systemic embolism (efficacy) and a composite of mortality, complications, or major bleeding (safety) at 1 year.
Main Results:
- No significant sex differences were observed in major peri-procedural complications (men 7.0% vs. women 4.9%, p=0.51).
- At 1-year follow-up, efficacy endpoints (ischemic stroke/systemic embolism: 2.6%) and safety endpoints (composite: 19.2%, major bleeding: 8.9%, all-cause mortality: 9.3%) were comparable between sexes (all p>0.1).
- Device implantation success rate exceeded 99% in both men and women.
Conclusions:
- Contrary to some prior reports, this real-world multicenter study found no significant sex disparities in peri-procedural or 1-year outcomes after LAAC.
- LAAC demonstrated comparable safety and efficacy in both men and women, supporting its role as a sex-independent stroke prevention strategy for AF patients.
- These findings reinforce the value of LAAC for reducing stroke risk in high-bleeding-risk AF patients, regardless of sex.
Abstract:
Background: Percutaneous left atrial appendage closure (LAAC) provides an alternative to oral anticoagulation (OAC) in atrial fibrillation (AF) patients who are at high bleeding risk. Prior studies have suggested sex-related differences in procedural outcomes, with women demonstrating higher peri-procedural complication rates. Data on long-term outcomes, however, remain inconsistent. Methods: We analyzed 407 consecutive patients with AF who underwent LAAC between 2010 and 2023 in four Israeli medical centers participating in the LEADER registry. Baseline characteristics, procedural data, and clinical outcomes were compared between men and women. The primary efficacy endpoint was ischemic stroke or systemic embolism at 1 year. The primary safety endpoint was a composite of all-cause mortality, procedural complications, or major bleeding at 1 year. Results: Of 407 patients, 285 (70%) were men and 122 (30%) were women. The mean age was 77 ± 8.4 years with similar CHA2DS2-VASc and HAS-BLED scores across sexes. Device implantation exceeded 99% in both sexes. Major peri-procedural complications occurred in 6.4% overall, without significant sex-based differences (men 7.0%, women 4.9%, p = 0.51). At 1-year follow-up, Kaplan-Meier estimates for the primary efficacy endpoint of ischemic stroke/systemic embolism (2.6%), the primary safety endpoint (19.2%), major bleeding (8.9%), and all-cause mortality (9.3%) were comparable between men and women (all p > 0.1). Conclusions: In contrast to prior large registries reporting higher peri-procedural risk in women, this real-world multicenter experience demonstrated no significant sex differences in either peri-procedural or long-term outcomes following LAAC. These findings support LAAC as an effective and safe stroke-prevention strategy in AF, irrespective of sex.
Related Concept Videos
Longitudinal Research
Regression Toward the Mean
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Longitudinal Studies
Comparing the Survival Analysis of Two or More Groups
Lateralization

